000 00988 a2200277 4500
005 20250518014734.0
264 0 _c20191230
008 201912s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.2018.205989
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBar-Natan, Michal
245 0 0 _aNew insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches.
_h[electronic resource]
260 _bHaematologica
_c01 2019
300 _a3-6 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aEndothelial Cells
650 0 4 _aHumans
650 0 4 _aMyeloproliferative Disorders
650 0 4 _aNeoplasms
650 0 4 _aP-Selectin
650 0 4 _aThrombosis
700 1 _aHoffman, Ronald
773 0 _tHaematologica
_gvol. 104
_gno. 1
_gp. 3-6
856 4 0 _uhttps://doi.org/10.3324/haematol.2018.205989
_zAvailable from publisher's website
999 _c29210411
_d29210411